BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30073425)

  • 1. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
    Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
    Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
    Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
    Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
    Paralkar VR; Li T; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.
    Nieder C; Hintz M; Oehlke O; Bilger A; Grosu AL
    Clin Transl Oncol; 2017 Sep; 19(9):1141-1146. PubMed ID: 28357633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.
    Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka S; Bebb DG; Cheung WY
    Am J Clin Oncol; 2019 Jan; 42(1):75-81. PubMed ID: 30211724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
    Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
    Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
    He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
    Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
    Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
    Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
    Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
    Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
    Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
    Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.
    Yang J; Zhang Y; Sun X; Gusdon AM; Song N; Chen L; Jiang G; Huang Y
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1835-1842. PubMed ID: 30003315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer Patients.
    Yamaguchi M; Edagawa M; Suzuki Y; Toyozawa R; Hirai F; Nosaki K; Seto T; Takenoyama M; Ichinose Y
    Ann Thorac Surg; 2017 May; 103(5):1594-1599. PubMed ID: 27863731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.
    Sakai K; Kuramoto J; Kojima A; Nishimura H; Kuwabara Y; Toda M; Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Gemma A; Uematsu K
    Int J Clin Oncol; 2019 Dec; 24(12):1549-1557. PubMed ID: 31452019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the Survival Time in the Non-small Cell Lung Cancer Patients with Different Organ Metastasis].
    Wu B; Wei S; Tian J; Song X; Hu P; Cui Y
    Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):105-110. PubMed ID: 30827327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathological characteristics and outcomes of 40 surgically treated stage M1b non-small cell lung cancer patients].
    Pan Y; Wang YL; Wang YG; Wang DL
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):63-67. PubMed ID: 30678419
    [No Abstract]   [Full Text] [Related]  

  • 20. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.